XML 53 R18.htm IDEA: XBRL DOCUMENT v3.22.4
Subsequent Events
12 Months Ended
Dec. 31, 2022
Subsequent Events [Abstract]  
Subsequent Events
11.
Subsequent Events

In February 2023, the Company and AbbVie amended the AbbVie agreement, which will result in the Company receiving a $17.8 million milestone payment for the dosing of the first patient in a long-term extension study.